0001593968-21-000225.txt : 20210128
0001593968-21-000225.hdr.sgml : 20210128
20210128112151
ACCESSION NUMBER: 0001593968-21-000225
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210126
FILED AS OF DATE: 20210128
DATE AS OF CHANGE: 20210128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waltz Todd
CENTRAL INDEX KEY: 0001383895
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36475
FILM NUMBER: 21563078
MAIL ADDRESS:
STREET 1: P O BOX 1445
CITY: CUPERTINO
STATE: CA
ZIP: 95015
FORMER NAME:
FORMER CONFORMED NAME: WELTZ TODD
DATE OF NAME CHANGE: 20061218
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AEMETIS, INC
CENTRAL INDEX KEY: 0000738214
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 261407544
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20400 STEVENS CREEK BLVD
STREET 2: SUITE 700
CITY: CUPERTINO
STATE: CA
ZIP: 95014
BUSINESS PHONE: 408-517-3304
MAIL ADDRESS:
STREET 1: 20400 STEVENS CREEK BLVD
STREET 2: SUITE 700
CITY: CUPERTINO
STATE: CA
ZIP: 95014
FORMER COMPANY:
FORMER CONFORMED NAME: AE BIOFUELS, INC.
DATE OF NAME CHANGE: 20110714
FORMER COMPANY:
FORMER CONFORMED NAME: AE Biofuels, Inc.
DATE OF NAME CHANGE: 20071212
FORMER COMPANY:
FORMER CONFORMED NAME: MARWICH II LTD
DATE OF NAME CHANGE: 19840123
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2021-01-26
0000738214
AEMETIS, INC
AMTX
0001383895
Waltz Todd
20400 STEVENS CREK BLVD, SUITE 700
CUPERTINO
CA
95014
false
true
false
false
Executive Vice President, CFO
Option (right to buy)
4.35
2021-01-26
4
D
false
10000
9.0609
D
2015-08-21
2022-05-21
Common stock and Series B Preferred
10000
0
D
The 10,000 shares were exercised from grant 5/21/2015 and sold through executing the 10b5-1 plan.
1/12th of the Option Shares vest every three(3)months from the date of the grant.
Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 20,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $4.35 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.
/s/ Todd Waltz
2021-01-28